New drug cocktail tested in battle against spreading lung cancer
NCT ID NCT03573947
Summary
This study tested a combination of three drugs—nivolumab, ipilimumab, and paclitaxel—for people newly diagnosed with advanced non-small cell lung cancer that had spread. The main goal was to see if this combination could safely control the cancer and delay its progression. It involved 46 participants who received the drugs and were monitored for up to four years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.